Latest News
The Blavatnik Fund for Innovation at Yale, made possible by a generous grant from the Blavatnik Family Foundation, supports Yale faculty in the commercialization of biomedical and digital health innovations.
- May 02, 2023Source: YaleNews
Searching for compounds with the therapeutic effects of ibogaine but not is toxicity, researchers found two that eased depression and opioid withdrawal in mice.
- April 10, 2023
Researchers found that a small synthetic molecule called Bobcat339 significantly weakened anorexia nervosa—as well as associated anxiety and depressive-like behaviors—in a mouse model, with few side effects.
- February 14, 2023Source: YaleNews
Kinases are essential for cell signaling. A new study matches kinases to their targets, enabling a deeper understanding of biological processes.
- February 13, 2023Source: Yale News
Kinases are essential for cell signaling. A new study matches hundreds of kinases to their targets, enabling a deeper understanding of biological processes.
- December 12, 2022Source: Yale Ventures
The 2022 Yale Life Science Pitchfest held on December 8, 2022 featured 31 Yale faculty innovators presenting breakthrough research projects in therapeutics, medical devices, and digital health to a crowd of over 325 people from 120+ companies, including 14 industry judges.
- December 11, 2022Source: Yale Ventures
The 2022 Yale Life Science Pitchfest held on December 8, 2022 featured 31 Yale faculty innovators presenting breakthrough research projects in therapeutics, medical devices, and digital health to a crowd of over 325 people from 120+ companies, including 14 industry judges.
- December 04, 2022
In a new study, Yale Cancer Center researchers found molecular explanations for why some lung tumors respond better to certain drugs than others. The research should help improve drug selection for lung cancer patients with different mutations in the EGF receptor, using a precision medicine approach to treatment.
- November 21, 2022
Mark A. Lemmon, PhD, will become chair of the Department of Pharmacology in July 2023.
- November 14, 2022
Q&A with Roy Herbst, MD, PhD, medical oncologist, in recognition of Lung Cancer Awareness Month.